EC
ABBV icon

EdgeRock Capital’s AbbVie ABBV Stock Holding History

EdgeRock Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656K Buy
2,608
+185
+8% +$39.8K 0.15% 68
2026
Q1 		$527K Buy
2,423
+98
+4% +$21.7K 0.14% 67
2025
Q4 		$531K Buy
2,325
+96
+4% +$21.9K 0.14% 69
2025
Q3 		$516K Buy
2,229
+75
+3% +$15.3K 0.14% 68
2025
Q2 		$399K Buy
2,154
+136
+7% +$25.3K 0.13% 69
2025
Q1 		$423K Buy
2,018
+113
+6% +$22K 0.3% 44
2024
Q4 		$339K Buy
1,905
+101
+6% +$18.6K 0.22% 52
2024
Q3 		$356K Buy
1,804
+88
+5% +$16.4K 0.25% 49
2024
Q2 		$294K Buy
1,716
+304
+22% +$50.4K 0.23% 43
2024
Q1 		$257K Buy
1,412
+47
+3% +$8.1K 0.2% 50
2023
Q4 		$232K Buy
+1,365
New +$199K 0.17% 53
2022
Q4 		– Sell
-866
Closed -$116K – 61
2022
Q3 		$116K Buy
+866
New +$124K 0.07% 73

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EdgeRock Capital's ABBV Position: Q2 2026 in Review

EdgeRock Capital increased its AbbVie (ABBV) stake by 7.6% in Q2 2026, buying an estimated $39.8K and bringing the position to 2,608 shares worth $656K. The position accounts for 0.15% of the portfolio, ranked #68.

EdgeRock Capital first reported a position in ABBV in Q3 2022 and has held it in 12 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • EdgeRock Capital held 2,608 shares of AbbVie worth $656K as of Q2 2026.
  • EdgeRock Capital bought 185 AbbVie shares in Q2 2026, an estimated $39.8K.
  • AbbVie made up 0.15% of EdgeRock Capital's portfolio in Q2 2026, its #68 holding.
  • EdgeRock Capital first reported a position in AbbVie in Q3 2022 and has held it in 12 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on EdgeRock Capital's 13F filing for Q2 2026, filed 24 Jul 2026.